Jackie’s Story
My name is Jackie Trapp. I live in Muskego, WI and have been married for 34 years to my wonderful, loving husband. In August of 2015, I was diagnosed with multiple myeloma, an incurable blood cancer.
Steven’s Story
My name is Steven Hadfield. I am 70 years old, a long-time North Carolinian, a husband, a grandfather of three, and a football fanatic. I’m also a rare cancer and type 2 diabetes patient.
JULY PRICE HIKES REPORT: Big Pharma’s Continued Greed Underscores Urgent Need For Reform To Lower Drug Prices
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients
July 2022 Price Hikes Report
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients
July 2022 Price Hikes Methodology and Data Set
Methodology and Dataset for July 2022 Price Hikes Report
The current drug pricing system isn’t working for patients like me.
My name is Emily. I’m a 26-year-old from Washington, D.C., and I live with psoriatic arthritis.
NEW REPORT: Big Pharma’s Lockstep Price Hikes On Widely Used Blood Thinners Exploit Patients And Taxpayers
A new report issued today documents how drug companies use their market and political power to avoid competition and raise prices in lockstep.
ELIQUIS AND XARELTO: LOCKSTEP PRICE HIKES AND PATENT GAMING EXPLOIT PATIENTS AND TAXPAYERS
This report examines the practices of BMS/Pfizer and Johnson & Johnson's lockstep price hikes and patent gaming on two blockbuster blood thinners and the implications for patients and taxpayers.
